Modeling new therapies for infantile spasms

Epilepsia

Volumn 51, Issue SUPPL. 3, 2010, Pages 27-33

  Chudomelova, Lenka ^a,b   Scantlebury, Morris H ^a   Raffo, Emmanuel ^a   Coppola, Antonietta ^a   Betancourth, David ^a,c   Galanopoulou, Aristea S ^a,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Adrenocorticotropic hormone; Infantile spasms; Models; mTOR; Rapamycin; Vigabatrin

Indexed keywords

CLONAZEPAM; CORTICOTROPIN; HYDROCORTISONE; IMMUNOGLOBULIN; LIPOSTEROID DERIVATIVE; NITRAZEPAM; PROTIRELIN; PYRIDOXINE; STEROID; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CONFERENCE PAPER; INFANTILE SPASM; KETOGENIC DIET; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; HUMANS; INFANT; MICE; RATS; RECEPTORS, GABA; SIROLIMUS; SPASMS, INFANTILE; VIGABATRIN;

EID: 77954466566     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02605.x     Document Type: Conference Paper

References (26)

1. Baram TZ. (2003) Treatment of infantile spasms: the ideal and the mundane. Epilepsia 44:993-994.
2. Baram TZ. (2007) Go "west," young man...The quest for animal models of infantile spasms (west syndrome). Epilepsy Curr 7:165-167.
3. Baram TZ, Schultz L. (1991) Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 61:97-101.
4. Chiron C, Dumas C, Jambaque I, Mumford J, Dulac O. (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26:389-395.
5. Cortez MA, Shen L, Wu Y, Aleem IS, Trepanier CH, Sadeghnia HR, Ashraf A, Kanawaty A, Liu CC, Stewart L, Snead OC III. (2009) Infantile spasms and Down syndrome: a new animal model. Pediatr Res 65:499-503.
6. Crino PB. (2009) Focal brain malformations: seizures, signaling, sequencing. Epilepsia 50(suppl 9):3-8.
7. Hrachovy RA, Frost JD Jr. (2003) Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 20:408-425.
8. Jansen LA, Peugh LD, Ojemann JG. (2008) GABA(A) receptor properties in catastrophic infantile epilepsy. Epilepsy Res 81:188-197.
9. Kabova R, Liptakova S, Slamberova R, Pometlova M, Velisek L. (1999) Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 40:1357-1369.
10. Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette P, Carmant L. (2009) A retrospective study on aetiology based outcome of infantile spasms. Seizure 18:197-201.
11. Kivity S, Lerman P, Ariel R, Danziger Y, Mimouni M, Shinnar S. (2004) Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 45:255-262.
12. Kossoff EH, Hartman AL, Rubenstein JE, Vining EP. (2009) High-dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH. Epilepsy Behav 14:674-676.
13. Kubova H, Mares P. (2009) Vigabatrin but not valproate prevents development of age-specific flexion seizures induced by N-methyl-Daspartate (NMDA) in immature rats. Epilepsia 51:469-472.
14. Lee CL, Frost JD Jr, Swann JW, Hrachovy RA. (2008) A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia 49:298-307.
15. Lombroso CT. (1983) A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia 24:135-158.
16. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP. (2005) The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 4:712-717.
17. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Snead OC III. (2004) Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 62:1668-1681.
18. Mares P, Velisek L. (1992) N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 65:185-189.
19. Marsh E, Fulp C, Gomez E, Nasrallah I, Minarcik J, Sudi J, Christian SL, Mancini G, Labosky P, Dobyns W, Brooks-Kayal A, Golden JA. (2009) Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 132:1563-1576.
20. Price MG, Yoo JW, Burgess DL, Deng F, Hrachovy RA, Frost JD Jr, Noebels JL. (2009) A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10 + 7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 29:8752-8763.
21. Raffo E, Coppola A, Scantlebury MH, Galanopoulou AS. (2009) Pharmacosensitivity of a rat model of symptomatic infantile spasms. Ann Neurol 66(suppl 13):S1.
22. Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshé SL. (2010) A model of symptomatic infantile spasms syndrome. Neurobiol Dis 37:604-612.
23. Stafstrom CE. (2009) Infantile spasms: a critical review of emerging animal models. Epilepsy Curr 9:75-81.
24. Velisek L, Jehle K, Asche S, Veliskova J. (2007) Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 61:109-119.
25. West WJ. (1841) On a peculiar form of infantile convulsions. Lancet 1:724-725.
26. Wong M. (2009) Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 51:27-36.